Key result
Novel SCN5A variants are linked to AF, identified in ~3% of patients vs. controls.
Why the study?
Genetic studies have identified ion channel gene variants in families segregating atrial fibrillation, but the association of SCN5A variants with AF vulnerability was not established.
Are SCN5A variants associated with atrial fibrillation?
Case-Control (n=735)
No
Are SCN5A variants associated with atrial fibrillation?
Absolute Event Rate: 2.7% vs 0%
p-value: p=0.001
Mutations or rare variants in the cardiac sodium channel gene SCN5A are associated with an increased susceptibility to atrial fibrillation.
SCN5A variants may increase AF susceptibility; hypothesis-generating for familial screening but should not yet change practice.
BACKGROUND: Genetic studies have identified ion channel gene variants in families segregating atrial fibrillation (AF), the most common arrhythmia in clinical practice. Here, we tested the hypothesis that vulnerability to AF is associated with variation in SCN5A, the gene encoding the cardiac sodium channel. METHODS AND RESULTS: We resequenced the entire SCN5A coding region in 375 subjects with either lone AF (n=118) or AF associated with heart disease (n=257). Controls (n=360) from the same population were then genotyped for the presence of mutations or rare variants identified in the AF cases. In 10 probands (2.7%), 8 novel variants not found in the control population (0%; P=0.001) were identified. All variants affect highly conserved residues in the SCN5A protein. In 6 families with >1 affected member, the novel variant cosegregated with AF. We also identified 11 rare missense variants in 12 probands (3.2%) that have previously been associated with inherited arrhythmia syndromes (eg, congenital long-QT syndrome and Brugada syndrome). CONCLUSIONS: Mutations or rare variants in SCN5A may predispose patients with or without underlying heart disease to AF. The findings of the present study expand the clinical spectrum of disorders of the cardiac sodium channel to include AF and represent important progress toward molecular phenotyping and directed rather than empirical therapy for this common arrhythmia.
No takes yet. Share an insight, caveat, or question.
Darbar et al. (2008) conducted a case-control in Atrial Fibrillation (n=735). SCN5A variants vs. Control population without AF was evaluated on Presence of novel SCN5A variants (p=0.001). Novel variants in the cardiac sodium channel gene SCN5A were identified in 2.7% of patients with atrial fibrillation compared to 0% of controls (P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: